$41.38
-0.04-0.10%
At close: -
$41.38
0.000.00%
After Hours: 4:02 PM EDT
Comments
Loading...
Ingevity Analyst Ratings and Price Targets | NYSE:NGVT | Benzinga
Ingevity Corp has a consensus price target of $60.5 based on the ratings of 6 analysts. The high is $92 issued by Loop Capital on March 24, 2023. The low is $38 issued by Wells Fargo on May 7, 2025. The 3 most-recent analyst ratings were released by Wells Fargo, Wells Fargo, and BMO Capital on May 7, 2025, April 9, 2025, and February 26, 2025, respectively. With an average price target of $45 between Wells Fargo, Wells Fargo, and BMO Capital, there's an implied 8.75% upside for Ingevity Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Wells Fargo
BMO Capital
Oppenheimer
Loop Capital
Jefferies
1calculated from analyst ratings
Analyst Ratings for Ingevity
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/07/2025 | Buy Now | -8.17% | Wells Fargo | Michael Sison64% | $32 → $38 | Maintains | Equal-Weight | Get Alert |
| 04/09/2025 | Buy Now | -22.67% | Wells Fargo | Michael Sison64% | $45 → $32 | Maintains | Equal-Weight | Get Alert |
| 02/26/2025 | Buy Now | 57.08% | BMO Capital | John McNulty59% | $62 → $65 | Upgrade | Market Perform → Outperform | Get Alert |
| 02/20/2025 | Buy Now | 49.83% | BMO Capital | John McNulty59% | $61 → $62 | Maintains | Market Perform | Get Alert |
| 10/31/2024 | Buy Now | 13.58% | BMO Capital | John McNulty59% | $40 → $47 | Maintains | Market Perform | Get Alert |
| 09/30/2024 | Buy Now | -3.33% | BMO Capital | John McNulty59% | $42 → $40 | Maintains | Market Perform | Get Alert |
| 08/05/2024 | Buy Now | 1.5% | BMO Capital | John McNulty59% | $45 → $42 | Maintains | Market Perform | Get Alert |
| 08/05/2024 | Buy Now | -3.33% | Wells Fargo | Michael Sison64% | $45 → $40 | Maintains | Equal-Weight | Get Alert |
| 08/01/2024 | Buy Now | 20.83% | Oppenheimer | Ian Zaffino63% | $58 → $50 | Maintains | Outperform | Get Alert |
| 07/11/2024 | Buy Now | 8.75% | Wells Fargo | Michael Sison64% | $55 → $45 | Maintains | Equal-Weight | Get Alert |
| 05/08/2024 | Buy Now | 32.91% | BMO Capital | John McNulty59% | $50 → $55 | Maintains | Market Perform | Get Alert |
| 05/07/2024 | Buy Now | 35.33% | Loop Capital | Christopher Kapsch45% | $49 → $56 | Maintains | Hold | Get Alert |
| 05/02/2024 | Buy Now | 40.16% | Oppenheimer | Ian Zaffino63% | $50 → $58 | Maintains | Outperform | Get Alert |
| 04/22/2024 | Buy Now | 49.83% | Jefferies | Daniel Rizzo43% | $52 → $62 | Upgrade | Hold → Buy | Get Alert |
| 02/23/2024 | Buy Now | 20.83% | Wells Fargo | Michael Sison64% | $43 → $50 | Maintains | Equal-Weight | Get Alert |
| 11/09/2023 | Buy Now | 3.91% | BMO Capital | John McNulty59% | $54 → $43 | Maintains | Market Perform | Get Alert |
| 10/03/2023 | Buy Now | 28.08% | Loop Capital | Christopher Kapsch45% | $62 → $53 | Downgrade | Buy → Hold | Get Alert |
| 08/07/2023 | Buy Now | 45% | BMO Capital | John McNulty59% | $71 → $60 | Downgrade | Outperform → Market Perform | Get Alert |
| 07/27/2023 | Buy Now | — | Loop Capital | Christopher Kapsch45% | — | Upgrade | Hold → Buy | Get Alert |
| 05/23/2023 | Buy Now | 32.91% | Wells Fargo | Michael Sison64% | $66 → $55 | Maintains | Equal-Weight | Get Alert |
| 05/09/2023 | Buy Now | 93.33% | BMO Capital | John McNulty59% | $100 → $80 | Maintains | Outperform | Get Alert |
| 05/05/2023 | Buy Now | 59.5% | Wells Fargo | Michael Sison64% | $80 → $66 | Maintains | Equal-Weight | Get Alert |
| 05/05/2023 | Buy Now | 54.66% | Loop Capital | Christopher Kapsch45% | $92 → $64 | Downgrade | Buy → Hold | Get Alert |
| 04/17/2023 | Buy Now | 93.33% | Wells Fargo | Michael Sison64% | $85 → $80 | Maintains | Equal-Weight | Get Alert |
| 03/24/2023 | Buy Now | 122.33% | Loop Capital | Garik Shmois62% | $100 → $92 | Maintains | Buy | Get Alert |
| 03/01/2023 | Buy Now | 105.41% | Wells Fargo | Michael Sison64% | $76 → $85 | Maintains | Equal-Weight | Get Alert |
| 02/02/2023 | Buy Now | 141.66% | Loop Capital | Christopher Kapsch45% | $81 → $100 | Upgrade | Hold → Buy | Get Alert |
| 01/09/2023 | Buy Now | 83.66% | Wells Fargo | Michael Sison64% | $73 → $76 | Maintains | Equal-Weight | Get Alert |
| 11/04/2022 | Buy Now | 76.41% | Wells Fargo | Michael Sison64% | $67 → $73 | Maintains | Equal-Weight | Get Alert |
| 10/18/2022 | Buy Now | 61.91% | Wells Fargo | Michael Sison64% | $74 → $67 | Maintains | Equal-Weight | Get Alert |
| 10/11/2022 | Buy Now | 110.25% | BMO Capital | John McNulty59% | $89 → $87 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Ingevity (NGVT) stock?
The latest price target for Ingevity (NYSE:NGVT) was reported by Wells Fargo on May 7, 2025. The analyst firm set a price target for $38.00 expecting NGVT to fall to within 12 months (a possible -8.17% downside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Ingevity (NGVT)?
The latest analyst rating for Ingevity (NYSE:NGVT) was provided by Wells Fargo, and Ingevity maintained their equal-weight rating.
When was the last upgrade for Ingevity (NGVT)?
The last upgrade for Ingevity Corp happened on February 26, 2025 when BMO Capital raised their price target to $65. BMO Capital previously had a market perform for Ingevity Corp.
When was the last downgrade for Ingevity (NGVT)?
The last downgrade for Ingevity Corp happened on October 3, 2023 when Loop Capital changed their price target from $62 to $53 for Ingevity Corp.
When is the next analyst rating going to be posted or updated for Ingevity (NGVT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ingevity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ingevity was filed on May 7, 2025 so you should expect the next rating to be made available sometime around May 7, 2026.
Is the Analyst Rating Ingevity (NGVT) correct?
While ratings are subjective and will change, the latest Ingevity (NGVT) rating was a maintained with a price target of $32.00 to $38.00. The current price Ingevity (NGVT) is trading at is $41.38, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
